Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ALFACALCIDOL IMPURITY B CRS (15 MG)

ALFACALCIDOL IMPURITY B CRS (15 MG)

ND

DISCOVER
TERPIN IMPURITY D CRS (0.15 MG)

TERPIN IMPURITY D CRS (0.15 MG)

ND

DISCOVER
FORMOTEROL FOR SYSTEM SUITABILITY CRS (10 MG)

FORMOTEROL FOR SYSTEM SUITABILITY CRS (10 MG)

43229-80-7

DISCOVER
NEBIVOLOL HYDROCHLORIDE CRS (35 MG)

NEBIVOLOL HYDROCHLORIDE CRS (35 MG)

654671-77-9

DISCOVER
NEBIVOLOL IMPURITY D CRS (0.006 MG)

NEBIVOLOL IMPURITY D CRS (0.006 MG)

NA

DISCOVER
NEBIVOLOL IMPURITY B CRS (0.003 MG)

NEBIVOLOL IMPURITY B CRS (0.003 MG)

NA

DISCOVER
AMYGDALIN CRS (15 MG)

AMYGDALIN CRS (15 MG)

ND

DISCOVER
ISOIMPERATORIN CRS (15 MG)

ISOIMPERATORIN CRS (15 MG)

ND

DISCOVER
ATORVASTATIN FOR PEAK IDENTIFICATION B CRS (5 MG)

ATORVASTATIN FOR PEAK IDENTIFICATION B CRS (5 MG)

ND

DISCOVER
NOTOPTERYGIUM RHIZOME AND ROOT FOR SYSTEM SUITABILITY HRS (2

NOTOPTERYGIUM RHIZOME AND ROOT FOR SYSTEM SUITABILITY HRS (2

ND

DISCOVER
NEBIVOLOL FOR PEAK IDENTIFICATION CRS (15 MG)

NEBIVOLOL FOR PEAK IDENTIFICATION CRS (15 MG)

NA

DISCOVER
PALLADIUM SOLUTION CRS (10.2 ML)

PALLADIUM SOLUTION CRS (10.2 ML)

ND

DISCOVER